SCHEMBL16619785

SCHEMBL16619785

CCC(C(=O)O)N(Cc1cccc(Cl)c1)Cc1cc2c(Br)nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)c2cc1[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TXNRD1 Q16881 1/20 0.32
CYP19A1 P11511 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RIPK1 Q13546 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16619786 0.82 MAPT (0.35) NPSR1
SCHEMBL16619720 0.78 CTSB (0.37)
SCHEMBL29584493 0.74 CYP19A1 (0.32) CYP19A1
SCHEMBL16620569 0.74 CYP19A1 (0.32) CYP19A1
SCHEMBL16620640 0.73 KMT2A (0.40) NPSR1
SCHEMBL16620027 0.73 CTSB (0.33) CYP19A1
SCHEMBL20916820 0.71 CTSB (0.35) CYP19A1NPSR1
SCHEMBL30554375 0.71 CTSB (0.35) CYP19A1NPSR1
SCHEMBL1201016 0.70 PIN1 (0.32) CYP19A1
SCHEMBL16620361 0.70 MEN1 (0.36) NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052096-A1 INHIBITORS OF ERK AND METHODS OF USE Kura Oncology, Inc. (US) 2016-08-10 EP disclosed
WO-2015051341-A1 INHIBITORS OF ERK AND METHODS OF USE ARAXES PHARMA LLC (US) 2015-04-09 WO disclosed